APOE c.305C>A ;(p.P102Q)

Variant ID: 19-45411858-C-A

NM_000041.2(APOE):c.305C>A;(p.P102Q)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Influence of CYP4F2, ApoE, and CYP2A6 gene polymorphisms on the variability of Warfarin dosage requirements and susceptibility to cardiovascular disease in Jordan.

International Journal Of Medical Sciences
Al-Eitan, Laith N LN; Almasri, Ayah Y AY; Alnaamneh, Adan H AH; Aman, Hatem A HA; Alrabadi, Nasr N NN; Khasawneh, Rame H RH; Alghamdi, Mansour A MA
Publication Date: 2021

Variant appearance in text: rs11083750
PubMed Link: 33437219
Variant Present in the following documents:
  • Main text
  • ijmsv18p0826.pdf
View BVdb publication page



Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk.

Journal Of Lipid Research
Zhou, Yitian Y; Mägi, Reedik R; Milani, Lili L; Lauschke, Volker M VM
Publication Date: 2018-10

Variant appearance in text: rs11083750
PubMed Link: 30076208
Variant Present in the following documents:
  • 10.1194_P086710_jlr.P086710-4.xlsx, sheet 3
View BVdb publication page



Screening and Evaluation of Deleterious SNPs in APOE Gene of Alzheimer's Disease.

Neurology Research International
Masoodi, Tariq Ahmad TA; Al Shammari, Sulaiman A SA; Al-Muammar, May N MN; Alhamdan, Adel A AA
Publication Date: 2012

Variant appearance in text: APOE: P102Q; rs11083750
PubMed Link: 22530123
Variant Present in the following documents:
  • Main text
  • NRI2012-480609.pdf
View BVdb publication page